Logo

Biosearch Technologies Licenses Genetic Technologies' Non-Coding DNA IP

Oct 09, 2007
NEW YORK (GenomeWeb News) — Genetic Technologies has licensed certain of its non-coding DNA patents to Biosearch Technologies for research purposes, GTG said today.
 
BTI will use the worldwide license, which includes IP for SNP genotyping and allelic discrimination, to manufacture and distribute oligos, probes, and primers for research use only.
 
All of BTI’s customers will be covered under the GTG patents, GTG said.
 
Financial terms of the agreement were not released.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.